Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature
Identifieur interne : 001F17 ( Istex/Corpus ); précédent : 001F16; suivant : 001F18Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature
Auteurs : Ken Yoshida ; Daitaro Kurosaka ; Isamu Kingetsu ; Kenichiro Hirai ; Akio YamadaSource :
- Rheumatology International [ 0172-8172 ] ; 2008-07-01.
English descriptors
Abstract
Abstract: We describe a 38-year-old man who presented with proximal muscle weakness, myalgia, polyarthralgia, and skin rash and was diagnosed as having dermatomyositis (DM). The patient’s symptoms improved with prednisolone therapy. However, myopathy relapsed and pneumomediastinum with subcutaneous emphysema developed. Pneumomediastinum with subcutaneous emphysema rapidly disappeared by the administration of ciclosporin. We reviewed the present case and previously reported cases regarding the clinical characteristics. All of the reported death cases were accompanied by interstitial lung disease (ILD). Although it has been reported that pneumomediastinum in DM can be fatal, the direct cause of patient’s death was due to respiratory failure resulting from progressive ILD. Pneumomediastinum without ILD shows a good prognosis.
Url:
DOI: 10.1007/s00296-008-0548-1
Links to Exploration step
ISTEX:426F457BABEE97B24BE64031BEF826779DD8A169Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature</title><author><name sortKey="Yoshida, Ken" sort="Yoshida, Ken" uniqKey="Yoshida K" first="Ken" last="Yoshida">Ken Yoshida</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: k.yoshida@jikei.ac.jp</mods:affiliation></affiliation></author><author><name sortKey="Kurosaka, Daitaro" sort="Kurosaka, Daitaro" uniqKey="Kurosaka D" first="Daitaro" last="Kurosaka">Daitaro Kurosaka</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</mods:affiliation></affiliation></author><author><name sortKey="Kingetsu, Isamu" sort="Kingetsu, Isamu" uniqKey="Kingetsu I" first="Isamu" last="Kingetsu">Isamu Kingetsu</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</mods:affiliation></affiliation></author><author><name sortKey="Hirai, Kenichiro" sort="Hirai, Kenichiro" uniqKey="Hirai K" first="Kenichiro" last="Hirai">Kenichiro Hirai</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</mods:affiliation></affiliation></author><author><name sortKey="Yamada, Akio" sort="Yamada, Akio" uniqKey="Yamada A" first="Akio" last="Yamada">Akio Yamada</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:426F457BABEE97B24BE64031BEF826779DD8A169</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1007/s00296-008-0548-1</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-S170VFP2-0/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001F17</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001F17</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature</title><author><name sortKey="Yoshida, Ken" sort="Yoshida, Ken" uniqKey="Yoshida K" first="Ken" last="Yoshida">Ken Yoshida</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: k.yoshida@jikei.ac.jp</mods:affiliation></affiliation></author><author><name sortKey="Kurosaka, Daitaro" sort="Kurosaka, Daitaro" uniqKey="Kurosaka D" first="Daitaro" last="Kurosaka">Daitaro Kurosaka</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</mods:affiliation></affiliation></author><author><name sortKey="Kingetsu, Isamu" sort="Kingetsu, Isamu" uniqKey="Kingetsu I" first="Isamu" last="Kingetsu">Isamu Kingetsu</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</mods:affiliation></affiliation></author><author><name sortKey="Hirai, Kenichiro" sort="Hirai, Kenichiro" uniqKey="Hirai K" first="Kenichiro" last="Hirai">Kenichiro Hirai</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</mods:affiliation></affiliation></author><author><name sortKey="Yamada, Akio" sort="Yamada, Akio" uniqKey="Yamada A" first="Akio" last="Yamada">Akio Yamada</name><affiliation><mods:affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Rheumatology International</title><title level="j" type="sub">Clinical and Experimental Investigations</title><title level="j" type="abbrev">Rheumatol Int</title><idno type="ISSN">0172-8172</idno><idno type="eISSN">1437-160X</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="2008-07-01">2008-07-01</date><biblScope unit="volume">28</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="913">913</biblScope><biblScope unit="page" to="917">917</biblScope></imprint><idno type="ISSN">0172-8172</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0172-8172</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Corticosteroids</term><term>Dermatomyositis</term><term>Interstitial lung disease</term><term>Pneumomediastinum</term><term>Vasculitis</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: We describe a 38-year-old man who presented with proximal muscle weakness, myalgia, polyarthralgia, and skin rash and was diagnosed as having dermatomyositis (DM). The patient’s symptoms improved with prednisolone therapy. However, myopathy relapsed and pneumomediastinum with subcutaneous emphysema developed. Pneumomediastinum with subcutaneous emphysema rapidly disappeared by the administration of ciclosporin. We reviewed the present case and previously reported cases regarding the clinical characteristics. All of the reported death cases were accompanied by interstitial lung disease (ILD). Although it has been reported that pneumomediastinum in DM can be fatal, the direct cause of patient’s death was due to respiratory failure resulting from progressive ILD. Pneumomediastinum without ILD shows a good prognosis.</div></front></TEI><istex><corpusName>springer-journals</corpusName><author><json:item><name>Ken Yoshida</name><affiliations><json:string>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</json:string><json:string>E-mail: k.yoshida@jikei.ac.jp</json:string></affiliations></json:item><json:item><name>Daitaro Kurosaka</name><affiliations><json:string>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</json:string></affiliations></json:item><json:item><name>Isamu Kingetsu</name><affiliations><json:string>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</json:string></affiliations></json:item><json:item><name>Kenichiro Hirai</name><affiliations><json:string>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</json:string></affiliations></json:item><json:item><name>Akio Yamada</name><affiliations><json:string>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Pneumomediastinum</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Dermatomyositis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Interstitial lung disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Vasculitis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Corticosteroids</value></json:item></subject><articleId><json:string>548</json:string><json:string>s00296-008-0548-1</json:string></articleId><arkIstex>ark:/67375/VQC-S170VFP2-0</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>OriginalPaper</json:string></originalGenre><abstract>Abstract: We describe a 38-year-old man who presented with proximal muscle weakness, myalgia, polyarthralgia, and skin rash and was diagnosed as having dermatomyositis (DM). The patient’s symptoms improved with prednisolone therapy. However, myopathy relapsed and pneumomediastinum with subcutaneous emphysema developed. Pneumomediastinum with subcutaneous emphysema rapidly disappeared by the administration of ciclosporin. We reviewed the present case and previously reported cases regarding the clinical characteristics. All of the reported death cases were accompanied by interstitial lung disease (ILD). Although it has been reported that pneumomediastinum in DM can be fatal, the direct cause of patient’s death was due to respiratory failure resulting from progressive ILD. Pneumomediastinum without ILD shows a good prognosis.</abstract><qualityIndicators><score>5.677</score><pdfWordCount>2345</pdfWordCount><pdfCharCount>15993</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>5</pdfPageCount><pdfPageSize>595 x 791 pts</pdfPageSize><refBibsNative>false</refBibsNative><abstractWordCount>111</abstractWordCount><abstractCharCount>834</abstractCharCount><keywordCount>5</keywordCount></qualityIndicators><title>Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature</title><genre><json:string>research-article</json:string></genre><host><title>Rheumatology International</title><language><json:string>unknown</json:string></language><publicationDate>2008</publicationDate><copyrightDate>2008</copyrightDate><issn><json:string>0172-8172</json:string></issn><eissn><json:string>1437-160X</json:string></eissn><journalId><json:string>296</json:string></journalId><volume>28</volume><issue>9</issue><pages><first>913</first><last>917</last></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Rheumatology</value></json:item></subject></host><ark><json:string>ark:/67375/VQC-S170VFP2-0</json:string></ark><publicationDate>2008</publicationDate><copyrightDate>2008</copyrightDate><doi><json:string>10.1007/s00296-008-0548-1</json:string></doi><id>426F457BABEE97B24BE64031BEF826779DD8A169</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-S170VFP2-0/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-S170VFP2-0/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/VQC-S170VFP2-0/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://scientific-publisher.data.istex.fr">Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><availability><licence><p>Springer-Verlag, 2008</p></licence><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</p></availability><date>2007-10-25</date></publicationStmt><notesStmt><note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note><note>Case Report</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature</title><author xml:id="author-0000" corresp="yes"><persName><forename type="first">Ken</forename><surname>Yoshida</surname></persName><email>k.yoshida@jikei.ac.jp</email><affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</affiliation></author><author xml:id="author-0001"><persName><forename type="first">Daitaro</forename><surname>Kurosaka</surname></persName><affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</affiliation></author><author xml:id="author-0002"><persName><forename type="first">Isamu</forename><surname>Kingetsu</surname></persName><affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</affiliation></author><author xml:id="author-0003"><persName><forename type="first">Kenichiro</forename><surname>Hirai</surname></persName><affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</affiliation></author><author xml:id="author-0004"><persName><forename type="first">Akio</forename><surname>Yamada</surname></persName><affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</affiliation></author><idno type="istex">426F457BABEE97B24BE64031BEF826779DD8A169</idno><idno type="ark">ark:/67375/VQC-S170VFP2-0</idno><idno type="DOI">10.1007/s00296-008-0548-1</idno><idno type="article-id">548</idno><idno type="article-id">s00296-008-0548-1</idno></analytic><monogr><title level="j">Rheumatology International</title><title level="j" type="sub">Clinical and Experimental Investigations</title><title level="j" type="abbrev">Rheumatol Int</title><idno type="pISSN">0172-8172</idno><idno type="eISSN">1437-160X</idno><idno type="journal-ID">true</idno><idno type="issue-article-count">22</idno><idno type="volume-issue-count">12</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="2008-07-01"></date><biblScope unit="volume">28</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="913">913</biblScope><biblScope unit="page" to="917">917</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2007-10-25</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Abstract: We describe a 38-year-old man who presented with proximal muscle weakness, myalgia, polyarthralgia, and skin rash and was diagnosed as having dermatomyositis (DM). The patient’s symptoms improved with prednisolone therapy. However, myopathy relapsed and pneumomediastinum with subcutaneous emphysema developed. Pneumomediastinum with subcutaneous emphysema rapidly disappeared by the administration of ciclosporin. We reviewed the present case and previously reported cases regarding the clinical characteristics. All of the reported death cases were accompanied by interstitial lung disease (ILD). Although it has been reported that pneumomediastinum in DM can be fatal, the direct cause of patient’s death was due to respiratory failure resulting from progressive ILD. Pneumomediastinum without ILD shows a good prognosis.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Pneumomediastinum</term></item><item><term>Dermatomyositis</term></item><item><term>Interstitial lung disease</term></item><item><term>Vasculitis</term></item><item><term>Corticosteroids</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Medicine & Public Health</head><item><term>Rheumatology</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2007-10-25">Created</change><change when="2008-07-01">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-S170VFP2-0/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus springer-journals not found" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//Springer-Verlag//DTD A++ V2.4//EN" URI="http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd" name="istex:docType"></istex:docType><istex:document><Publisher><PublisherInfo><PublisherName>Springer-Verlag</PublisherName><PublisherLocation>Berlin/Heidelberg</PublisherLocation></PublisherInfo><Journal OutputMedium="All"><JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered"><JournalID>296</JournalID><JournalPrintISSN>0172-8172</JournalPrintISSN><JournalElectronicISSN>1437-160X</JournalElectronicISSN><JournalTitle>Rheumatology International</JournalTitle><JournalSubTitle>Clinical and Experimental Investigations</JournalSubTitle><JournalAbbreviatedTitle>Rheumatol Int</JournalAbbreviatedTitle><JournalSubjectGroup><JournalSubject Type="Primary">Medicine & Public Health</JournalSubject><JournalSubject Type="Secondary">Rheumatology </JournalSubject></JournalSubjectGroup></JournalInfo><Volume OutputMedium="All"><VolumeInfo TocLevels="0" VolumeType="Regular"><VolumeIDStart>28</VolumeIDStart><VolumeIDEnd>28</VolumeIDEnd><VolumeIssueCount>12</VolumeIssueCount></VolumeInfo><Issue IssueType="Regular" OutputMedium="All"><IssueInfo IssueType="Regular" TocLevels="0"><IssueIDStart>9</IssueIDStart><IssueIDEnd>9</IssueIDEnd><IssueArticleCount>22</IssueArticleCount><IssueHistory><OnlineDate><Year>2008</Year><Month>6</Month><Day>5</Day></OnlineDate><PrintDate><Year>2008</Year><Month>6</Month><Day>5</Day></PrintDate><CoverDate><Year>2008</Year><Month>7</Month></CoverDate></IssueHistory><IssueCopyright><CopyrightHolderName>Springer-Verlag</CopyrightHolderName><CopyrightYear>2008</CopyrightYear></IssueCopyright></IssueInfo><Article ID="s00296-008-0548-1" OutputMedium="All"><ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0"><ArticleID>548</ArticleID><ArticleDOI>10.1007/s00296-008-0548-1</ArticleDOI><ArticleSequenceNumber>15</ArticleSequenceNumber><ArticleTitle Language="En" OutputMedium="All">Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature</ArticleTitle><ArticleCategory>Case Report</ArticleCategory><ArticleFirstPage>913</ArticleFirstPage><ArticleLastPage>917</ArticleLastPage><ArticleHistory><RegistrationDate><Year>2008</Year><Month>2</Month><Day>19</Day></RegistrationDate><Received><Year>2007</Year><Month>10</Month><Day>25</Day></Received><Accepted><Year>2008</Year><Month>2</Month><Day>15</Day></Accepted><OnlineDate><Year>2008</Year><Month>2</Month><Day>29</Day></OnlineDate></ArticleHistory><ArticleCopyright><CopyrightHolderName>Springer-Verlag</CopyrightHolderName><CopyrightYear>2008</CopyrightYear></ArticleCopyright><ArticleGrants Type="Regular"><MetadataGrant Grant="OpenAccess"></MetadataGrant><AbstractGrant Grant="OpenAccess"></AbstractGrant><BodyPDFGrant Grant="Restricted"></BodyPDFGrant><BodyHTMLGrant Grant="Restricted"></BodyHTMLGrant><BibliographyGrant Grant="Restricted"></BibliographyGrant><ESMGrant Grant="Restricted"></ESMGrant></ArticleGrants></ArticleInfo><ArticleHeader><AuthorGroup><Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1"><AuthorName DisplayOrder="Western"><GivenName>Ken</GivenName><FamilyName>Yoshida</FamilyName></AuthorName><Contact><Phone>+81-3-34331111</Phone><Fax>+81-3-35789078</Fax><Email>k.yoshida@jikei.ac.jp</Email></Contact></Author><Author AffiliationIDS="Aff1"><AuthorName DisplayOrder="Western"><GivenName>Daitaro</GivenName><FamilyName>Kurosaka</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1"><AuthorName DisplayOrder="Western"><GivenName>Isamu</GivenName><FamilyName>Kingetsu</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1"><AuthorName DisplayOrder="Western"><GivenName>Kenichiro</GivenName><FamilyName>Hirai</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1"><AuthorName DisplayOrder="Western"><GivenName>Akio</GivenName><FamilyName>Yamada</FamilyName></AuthorName></Author><Affiliation ID="Aff1"><OrgDivision>Division of Rheumatology, Department of Internal Medicine</OrgDivision><OrgName>Jikei University School of Medicine</OrgName><OrgAddress><Street>3-25-8, Nishi-shinbashi, Minato-ku</Street><City>Tokyo</City><Postcode>105-8461</Postcode><Country Code="JP">Japan</Country></OrgAddress></Affiliation></AuthorGroup><Abstract ID="Abs1" Language="En" OutputMedium="All"><Heading>Abstract</Heading><Para>We describe a 38-year-old man who presented with proximal muscle weakness, myalgia, polyarthralgia, and skin rash and was diagnosed as having dermatomyositis (DM). The patient’s symptoms improved with prednisolone therapy. However, myopathy relapsed and pneumomediastinum with subcutaneous emphysema developed. Pneumomediastinum with subcutaneous emphysema rapidly disappeared by the administration of ciclosporin. We reviewed the present case and previously reported cases regarding the clinical characteristics. All of the reported death cases were accompanied by interstitial lung disease (ILD). Although it has been reported that pneumomediastinum in DM can be fatal, the direct cause of patient’s death was due to respiratory failure resulting from progressive ILD. Pneumomediastinum without ILD shows a good prognosis.</Para></Abstract><KeywordGroup Language="En" OutputMedium="All"><Heading>Keywords</Heading><Keyword>Pneumomediastinum</Keyword><Keyword>Dermatomyositis</Keyword><Keyword>Interstitial lung disease</Keyword><Keyword>Vasculitis</Keyword><Keyword>Corticosteroids</Keyword></KeywordGroup></ArticleHeader><NoBody></NoBody></Article></Issue></Volume></Journal></Publisher></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature</title></titleInfo><name type="personal" displayLabel="corresp"><namePart type="given">Ken</namePart><namePart type="family">Yoshida</namePart><affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</affiliation><affiliation>E-mail: k.yoshida@jikei.ac.jp</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Daitaro</namePart><namePart type="family">Kurosaka</namePart><affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Isamu</namePart><namePart type="family">Kingetsu</namePart><affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Kenichiro</namePart><namePart type="family">Hirai</namePart><affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Akio</namePart><namePart type="family">Yamada</namePart><affiliation>Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="OriginalPaper" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre><originInfo><publisher>Springer-Verlag</publisher><place><placeTerm type="text">Berlin/Heidelberg</placeTerm></place><dateCreated encoding="w3cdtf">2007-10-25</dateCreated><dateIssued encoding="w3cdtf">2008-07-01</dateIssued><copyrightDate encoding="w3cdtf">2008</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><abstract lang="en">Abstract: We describe a 38-year-old man who presented with proximal muscle weakness, myalgia, polyarthralgia, and skin rash and was diagnosed as having dermatomyositis (DM). The patient’s symptoms improved with prednisolone therapy. However, myopathy relapsed and pneumomediastinum with subcutaneous emphysema developed. Pneumomediastinum with subcutaneous emphysema rapidly disappeared by the administration of ciclosporin. We reviewed the present case and previously reported cases regarding the clinical characteristics. All of the reported death cases were accompanied by interstitial lung disease (ILD). Although it has been reported that pneumomediastinum in DM can be fatal, the direct cause of patient’s death was due to respiratory failure resulting from progressive ILD. Pneumomediastinum without ILD shows a good prognosis.</abstract><note>Case Report</note><subject lang="en"><genre>Keywords</genre><topic>Pneumomediastinum</topic><topic>Dermatomyositis</topic><topic>Interstitial lung disease</topic><topic>Vasculitis</topic><topic>Corticosteroids</topic></subject><relatedItem type="host"><titleInfo><title>Rheumatology International</title><subTitle>Clinical and Experimental Investigations</subTitle></titleInfo><titleInfo type="abbreviated"><title>Rheumatol Int</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><originInfo><publisher>Springer</publisher><dateIssued encoding="w3cdtf">2008-06-05</dateIssued><copyrightDate encoding="w3cdtf">2008</copyrightDate></originInfo><subject><genre>Medicine & Public Health</genre><topic>Rheumatology</topic></subject><identifier type="ISSN">0172-8172</identifier><identifier type="eISSN">1437-160X</identifier><identifier type="JournalID">296</identifier><identifier type="IssueArticleCount">22</identifier><identifier type="VolumeIssueCount">12</identifier><part><date>2008</date><detail type="volume"><number>28</number><caption>vol.</caption></detail><detail type="issue"><number>9</number><caption>no.</caption></detail><extent unit="pages"><start>913</start><end>917</end></extent></part><recordInfo><recordOrigin>Springer-Verlag, 2008</recordOrigin></recordInfo></relatedItem><identifier type="istex">426F457BABEE97B24BE64031BEF826779DD8A169</identifier><identifier type="ark">ark:/67375/VQC-S170VFP2-0</identifier><identifier type="DOI">10.1007/s00296-008-0548-1</identifier><identifier type="ArticleID">548</identifier><identifier type="ArticleID">s00296-008-0548-1</identifier><accessCondition type="use and reproduction" contentType="copyright">Springer-Verlag, 2008</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-3XSW68JL-F">springer</recordContentSource><recordOrigin>Springer-Verlag, 2008</recordOrigin></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/VQC-S170VFP2-0/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F17 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001F17 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:426F457BABEE97B24BE64031BEF826779DD8A169
|texte= Pneumomediastinum in dermatomyositis itself is not a poor prognostic factor: report of a case and review of the literature
}}
| This area was generated with Dilib version V0.6.33. |  |